Chengdu Kanghua Valuation
| 300841 Stock | 63.61 1.13 1.81% |
At this time, the firm appears to be overvalued. Chengdu Kanghua Biol shows a prevailing Real Value of USD50.59 per share. The current price of the firm is USD63.61. Our model approximates the value of Chengdu Kanghua Biol from analyzing the firm fundamentals such as profit margin of 0.33 %, and Return On Equity of 0.16 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.4479 | Enterprise Value 7.9 B | Enterprise Value Ebitda 12.4849 | Price Sales 5.1534 | Trailing PE 15.5024 |
Overvalued
Today
Please note that Chengdu Kanghua's price fluctuation is very steady at this time. Calculation of the real value of Chengdu Kanghua Biol is based on 3 months time horizon. Increasing Chengdu Kanghua's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chengdu Kanghua is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chengdu Stock. However, Chengdu Kanghua's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.61 | Real 50.59 | Hype 63.61 | Naive 64.52 |
The real value of Chengdu Stock, also known as its intrinsic value, is the underlying worth of Chengdu Kanghua Biol Company, which is reflected in its stock price. It is based on Chengdu Kanghua's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chengdu Kanghua's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chengdu Kanghua Biological helps investors to forecast how Chengdu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chengdu Kanghua more accurately as focusing exclusively on Chengdu Kanghua's fundamentals will not take into account other important factors: Chengdu Kanghua Cash |
|
Chengdu Kanghua Total Value Analysis
Chengdu Kanghua Biological is presently forecasted to have takeover price of 7.91 B with market capitalization of 8.49 B, debt of 190.91 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chengdu Kanghua fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.91 B | 8.49 B | 190.91 M |
Chengdu Kanghua Investor Information
About 36.0% of the company shares are owned by insiders or employees . The book value of Chengdu Kanghua was presently reported as 26.59. The company last dividend was issued on the 8th of May 2024. Chengdu Kanghua Biol had 1.5:1 split on the 25th of May 2022. Based on the key measurements obtained from Chengdu Kanghua's financial statements, Chengdu Kanghua Biological is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 693.1 M | 660.1 M |
|
| |||||
| Operating Income | 408.8 M | 707.8 M |
|
|
Chengdu Kanghua Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chengdu Kanghua has an asset utilization ratio of 37.47 percent. This suggests that the Company is making USD0.37 for each dollar of assets. An increasing asset utilization means that Chengdu Kanghua Biological is more efficient with each dollar of assets it utilizes for everyday operations.Chengdu Kanghua Ownership Allocation
Chengdu Kanghua holds a total of 132.95 Million outstanding shares. Chengdu Kanghua Biological retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chengdu Kanghua Profitability Analysis
The company reported the revenue of 1.58 B. Net Income was 509.22 M with profit before overhead, payroll, taxes, and interest of 1.55 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chengdu Kanghua's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chengdu Kanghua and how it compares across the competition.
About Chengdu Kanghua Valuation
The stock valuation mechanism determines Chengdu Kanghua's current worth on a weekly basis. Our valuation model uses a comparative analysis of Chengdu Kanghua. We calculate exposure to Chengdu Kanghua's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chengdu Kanghua's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.7 B | 877.6 M |
Chengdu Kanghua Quarterly Retained Earnings |
|
Complementary Tools for Chengdu Stock analysis
When running Chengdu Kanghua's price analysis, check to measure Chengdu Kanghua's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chengdu Kanghua is operating at the current time. Most of Chengdu Kanghua's value examination focuses on studying past and present price action to predict the probability of Chengdu Kanghua's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chengdu Kanghua's price. Additionally, you may evaluate how the addition of Chengdu Kanghua to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |